Measuring how well patients stick to HIV treatment using new sensors
Official title: APTASENSORS FOR MEASURING LONG TERM ADHERENCE TO TENOFOVIR-BASED AND LONG ACTING HIV TREATMENT REGIMENS
Funded at Base Pair Biotechnologies, INC. · NIH-11222462 · Data updated 2026-11-12
This study is testing new sensors that can help track how well people with HIV are sticking to their medication routine, specifically with tenofovir, so that patients can get real-time feedback and improve their health.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Base Pair Biotechnologies, INC. NIH-funded |
| Lab location | 1 site (Pearland, United States) |
| Project start | September 15, 2024 |
| Project end | September 14, 2025 |
| Funding year | 2024 |
| Award (this year) | $300,000 |
| NIH project number | 75N95024C00033-0-9999-1 |
| Project ID | NIH-11222462 on NIH RePORTER |
Who could benefit from this research
✓Could help
Ideal candidates for this research are individuals living with HIV who are prescribed tenofovir-based treatment regimens.
✕Less likely to help
Patients who are not on tenofovir-based treatments or those who are not living with HIV may not receive any benefit from this research.
What this research studies
This research focuses on developing innovative sensors called Aptasensors that can accurately measure how well patients adhere to their HIV treatment regimens, specifically those involving tenofovir. By utilizing these sensors, the study aims to provide real-time feedback on medication adherence, which is crucial for effective HIV management. Patients participating in this research will help evaluate the effectiveness of these sensors in tracking their treatment over time, potentially leading to improved health outcomes. The approach combines advanced biotechnology with patient-centered monitoring to enhance treatment adherence.
Why it matters
Potential benefit: If successful, this research could lead to better monitoring of HIV treatment adherence, ultimately improving health outcomes for patients living with HIV.
How similar studies have gone: While the use of sensors for medication adherence is a growing field, this specific application of Aptasensors for HIV treatment adherence is relatively novel and has not been extensively tested in prior studies.
Where this research is happening
-
Base Pair Biotechnologies, INC.
Pearland, United States Active
Researchers
- Principal investigator: Jackson, George W — Base Pair Biotechnologies, INC.
- Study coordinator: Jackson, George W
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page.